Arg‐Gly‐Asp (RGD) peptide conjugated poly(lactic acid)–poly(ethylene oxide) micelle for targeted drug delivery
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In this study, a new poly(lactic acid)–poly (ethylene oxide)‐Arg‐Gly‐Asp (PLA‐PEO‐RGD) derivative was synthesized, and paclitaxel‐loaded PLA‐PEO‐RGD micelles were prepared by this derivative. The solubility assay showed that micelles mixed with Pluronic F‐68 as surfactant could increase the solubility of this hydrophobic paclitaxel in aqueous solution. The cell‐binding assay showed that PLA‐PEO‐RGD micelle (IC 50 = 11.13 ± 1.38 nmol/L) had about 3.6‐fold higher integrin avidity than PLA‐PEO‐RGD conjugates (IC 50 = 40.33 ± 3.12 nmol/L). The avidity of micelle was also higher than RGD4C peptide (IC 50 = 24.44 ± 1.21 nmol/L). The in vitro drug release profile of drug‐loaded PLA‐PEO‐RGD micelles exhibited initial burst release to 37% ± 2% (w/w) during the first 12 h, and then the release rate became steady in a controlled release manner. Furthermore, treatment of the MDA‐MB‐435 breast cancer cell line with paclitaxel‐loaded PLA‐PEO‐RGD micelles yielded cytotoxicities, with EC 50 values of ∼30 μmol/L. The paclitaxel‐loaded PLA‐PEO‐RGD micelles treated group showed the most dramatic tumor reduction in MDA‐MB‐435 tumor‐bearing nude mice, and the final mean tumor load was 31 ± 16 mm 3 (mean ± SD; n = 8). 125 I‐labeled micelles administration resulted in significant (p < 0.001) higher tumor uptake (2.68% ± 0.14%, ID/g) of PLA‐PEO‐RGD micelles compared to PLA‐PEO micelles (0.84% ± 0.09%, ID/g) after 2.5 h postinjection. Biodistribution study showed the best blood clearance of PLA‐PEO‐RGD micelles after 4.5 h postinjection. The results of this study suggest that paclitaxel‐loaded PLA‐PEO‐RGD micelles based on the specific recognition of α V β 3 integrin represent a potential and powerful target delivery technology. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Langer, R. (1990) · Science · doi:10.1126/science.2218494 · Cited by 1,778
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Cited by
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Kim, S., Shi, Y., Kim, J. Y., Park, K., & Cheng, J.-X. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903380446 · Cited by 549
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Gullotti, E., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900090z · Cited by 473
Recent advances in polymeric micelles for anti-cancer drug delivery
Biswas, S., Kumari, P., Lakhani, P. M., & Ghosh, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.031 · Cited by 471
Metadata
- Authors
- Hu, Z., Luo, F., Pan, Y., Hou, C., Ren, L., Chen, J., Wang, J., & Zhang, Y.
- Venue
- Journal of Biomedical Materials Research Part A
- Publisher
- Wiley
- Published
- 2007-09-26
- Volume
- 85A
- Issue
- 3
- Pages
- 797-807
- ISSN
- 1549-3296 (ISSN-L)
- 1552-4965
- OpenAlex
- W2042015935
- Cited by
- 79
- References
- 3
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.